| 10X GENOMICS INC | COM | $962K | 0.6% | 59,000 SH | New |
| ACADIA PHARMACEUTICALS INC | COM | $4.6M | 2.7%Prev: 5.1% | 171,000 SH | Decreased-167,400 SH |
| ALKERMES PLC | SHS | $1.4M | 0.8%Prev: 1.2% | 50,000 SH | Decreased |
| ALPHATEC HOLDINGS INC | COM | $380K | 0.2%Prev: 0.4% | 18,058 SH | Decreased-39,942 SH |
| ALUMIS INC | COM | $98K | 0.1%Prev: 0.1% | 10,000 SH | Increased |
| AMICUS THERAPEUTICS INC | COM | $3.6M | 2.1%Prev: 0.2% | 253,000 SH | Increased+225,000 SH |
| APELLIS PHARMACEUTICALS INC | COM | $352K | 0.2%Prev: 0.4% | 14,000 SH | Decreased |
| APOGEE THERAPEUTICS INC | COM | $1.2M | 0.7% | 16,000 SH | New |
| AXSOME THERAPEUTICS INC | COM | $1.1M | 0.6%Prev: 0.3% | 6,061 SH | Increased+2,061 SH |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | $3.3M | 1.9% | 462,700 SH | New |
| BIODESIX INC | COM | $2.0M | 1.1%Prev: 7.1% | 286,804 SH | Decreased-5,449,309 SH |
| BIOHAVEN LTD | COM | $670K | 0.4% | 59,365 SH | New |
| BRIDGEBIO PHARMA INC | COM | $665K | 0.4% | 8,688 SH | New |
| BRISTOL-MYERS SQUIBB CO | COM | $16.3M | 9.6%Prev: 31.5% | 302,842 SH | Decreased-382,340 SH |
| CANDEL THERAPEUTICS INC | COM | $339K | 0.2%Prev: 0.4% | 60,000 SH | Decreased |
| CASTLE BIOSCIENCES INC | COM | $3.1M | 1.8%Prev: 1.7% | 80,600 SH | Increased+2,600 SH |
| COMPASS THERAPEUTICS INC | COM | $8.6M | 5.0% | 1,592,938 SH | New |
| CORCEPT THERAPEUTICS INC | COM | $2.3M | 1.4%Prev: 3.0% | 67,200 SH | Decreased-6,800 SH |
| CULLINAN THERAPEUTICS INC | COM | $207K | 0.1% | 20,000 SH | New |
| CYTOKINETICS INC | COM | $1.9M | 1.1%Prev: 0.4% | 30,000 SH | Increased+20,000 SH |
| DOCGO INC | COM | $44K | 0.0%Prev: 2.6% | 49,908 SH | Decreased-714,154 SH |
| ELUTIA INC | COM | $182K | 0.1%Prev: 3.7% | 263,018 SH | Decreased-962,471 SH |
| EQT CORPORATION | COM | $1.9M | 1.1%Prev: 1.3% | 34,619 SH | Increased |
| FOGHORN THERAPEUTICS INC | COM | $1.5M | 0.9%Prev: 1.2% | 281,730 SH | Increased-29,200 SH |
| FREEPORT-MCMORAN CL-B | CL-B | $917K | 0.5% | 18,046 SH | New |
| GOSSAMER BIO INC | COM | $428K | 0.3%Prev: 0.1% | 138,176 SH | Increased |
| HALOZYME THERAPEUTICS INC | COM | $680K | 0.4%Prev: 0.4% | 10,100 SH | Increased+100 SH |
| HARROW HEALTH INC | COM | $1.7M | 1.0%Prev: 2.0% | 34,000 SH | Decreased-38,910 SH |
| ILLUMINA INC | COM | $787K | 0.5% | 6,000 SH | New |
| IMMUNOME INC | COM | $2.8M | 1.6% | 130,000 SH | New |
| INHIBRX BIOSCIENCES INC | COM | $292K | 0.2%Prev: 0.4% | 3,698 SH | Decreased-28,412 SH |
| INTELLIA THERAPEUTICS INC | COM | $2.8M | 1.7% | 315,400 SH | New |
| KALVISTA PHARMACEUTICALS INC | COM | $921K | 0.5%Prev: 0.5% | 57,000 SH | Increased-10,000 SH |
| KAYNE ANDERSON BDC INC | COM SHS | $286K | 0.2% | 20,000 SH | New |
| KLA CORPORATION | COM NEW | $26.6M | 15.6% | 21,883 SH | New |
| LAM RESEARCH CORPORATION | COM NEW | $6.9M | 4.0% | 40,329 SH | New |
| LIQUIDIA TECHNOLOGIES INC | COM | $345K | 0.2% | 10,000 SH | New |
| MASIMO CORP | COM | $1.1M | 0.6%Prev: 2.1% | 8,280 SH | Decreased-7,000 SH |
| NEKTAR THERAPEUTICS | COM | $1.3M | 0.8% | 31,000 SH | New |
| NEUROCRINE BIOSCIENCES INC | COM | $3.9M | 2.3%Prev: 3.4% | 27,190 SH | Decreased-3,050 SH |
| NOVOCURE LTD | ORD SHS | $2.0M | 1.2%Prev: 0.8% | 152,100 SH | Increased+121,100 SH |
| OLEMA PHARMACEUTICALS INC | COM | $6.7M | 3.9% | 269,000 SH | New |
| OUTSET MEDICAL INC | COM | $367K | 0.2%Prev: 0.3% | 98,913 SH | Decreased-269,853 SH |
| OVINTIV INC | COM | $4.2M | 2.5%Prev: 1.7% | 107,500 SH | Increased+55,300 SH |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | COM | $935K | 0.5% | 500,000 SH | New |
| PHARVARIS N V | COM | $828K | 0.5% | 29,847 SH | New |
| PHATHOM PHARMACEUTICALS INC | COM | $3.2M | 1.9% | 195,000 SH | New |
| PHREESIA INC | COM | $1.9M | 1.1%Prev: 2.3% | 110,700 SH | Decreased-4,000 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $4.8M | 2.8%Prev: 1.5% | 55,000 SH | Increased+7,000 SH |
| PROTHENA CORP PLC | SHS | $4.2M | 2.5%Prev: 3.4% | 441,019 SH | Decreased+136,445 SH |
| PULMONX CORP | COM | $554K | 0.3%Prev: 0.3% | 250,573 SH | Increased+199,573 SH |
| QUIDELORTHO CORP | COM | $2.1M | 1.2%Prev: 2.5% | 72,548 SH | Decreased+4,929 SH |
| RAPT THERAPEUTICS INC | COM NEW | $508K | 0.3% | 15,000 SH | New |
| SOLID BIOSCIENCES INC | COM NEW | $4.0M | 2.3% | 705,955 SH | New |
| STOKE THERAPEUTICS INC | COM | $8.3M | 4.8%Prev: 1.9% | 260,000 SH | Increased+50,000 SH |
| STRUCTURE THERAPEUTICS INC | SPONS ADR | $6.3M | 3.7% | 90,000 SH | New |
| TRAVERE THERAPEUTICS INC | COM | $1.6M | 1.0%Prev: 2.1% | 43,000 SH | Decreased-105,000 SH |
| TREACE MEDICAL CONCEPTS INC | COM | $556K | 0.3%Prev: 1.0% | 226,947 SH | Decreased+65,597 SH |
| TRINITY CAP INC | COM | $293K | 0.2% | 20,000 SH | New |
| ULTRAGENYX PHARMACEUTICAL INC | COM | $1.4M | 0.8%Prev: 0.5% | 62,000 SH | Increased+46,000 SH |
| UNIQURE NV | SHS | $737K | 0.4%Prev: 0.3% | 30,789 SH | Increased+10,789 SH |
| UNITED THERAPEUTICS CORP | COM | $1.5M | 0.9%Prev: 2.9% | 3,000 SH | Decreased-7,000 SH |
| VENTYX BIOSCIENCES INC | COM | $910K | 0.5%Prev: 0.1% | 100,827 SH | Increased+72,027 SH |
| VERA THERAPEUTICS INC | CL A | $2.2M | 1.3% | 44,000 SH | New |
| VERASTEM INC | COM NEW | $1.2M | 0.7% | 150,000 SH | New |
| VOYAGER THERAPEUTICS INC | COM | $294K | 0.2% | 74,918 SH | New |
| XENON PHARMACEUTICALS INC | COM | $941K | 0.6%Prev: 0.3% | 21,000 SH | Increased+11,000 SH |
| ZENTALIS PHARMACEUTICALS INC | COM | $23K | 0.0%Prev: 0.0% | 17,000 SH | Decreased |